Trial Profile
Retrospective study of treatment response by 99mTc-MIP-1404 SPECT/CT in patients with metastatic prostate cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Oct 2020
Price :
$35
*
At a glance
- Drugs Technetium tc 99m trofolastat (Primary)
- Indications Prostate cancer
- Focus Diagnostic use; Therapeutic Use
- 16 Oct 2018 New trial record